Showing results (91-100 of 378) with videos related to
Sort By:
Pageof 38
Annals of Medicine|June 19, 2001
Therapeutic potential of the intestinotropic hormone, glucagon-like peptide-2M C L'Heureux, P L BrubakerJournal of Occupational Health Psychology|May 1, 2001
The effects of job insecurity on employee safety outcomes: cross-sectional and longitudinal explorationsT M Probst, T L BrubakerAmerican Journal of Physiology. Gastrointestinal and Liver Physiology|April 30, 2011
The "cryptic" mechanism of action of glucagon-like peptide-2Katherine J Rowland, Patricia L BrubakerEndocrine|December 15, 2010
Mechanism of action of glucagon-like peptide-1(7-36NH2) in isolated rat pancreatic islets and abrogation of its effects in long-term incubationsK A Gronau, P L BrubakerAmerican Journal of Obstetrics and Gynecology|January 4, 2006
Incidence of malignancy in hormone therapy users with indeterminate calcifications on mammogramDenise M Lochner, Katherine L BrubakerAmerican Journal of Physiology. Endocrinology and Metabolism|July 27, 2007
Frontiers in glucagon-like peptide-2: multiple actions, multiple mediatorsPhilip E Dubé, Patricia L BrubakerNature Reviews. Gastroenterology & Hepatology|October 3, 2012
Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasisCharlotte X Dong, Patricia L BrubakerInternational Urogynecology Journal and Pelvic Floor Dysfunction|October 8, 2003
Rehabilitation of the short pelvic floor. II: Treatment of the patient with the short pelvic floorM P FitzGerald, R KotarinosProgress in Clinical and Biological Research|January 1, 1990
Evaluation of the bioluminescence assays as screens for genotoxic chemicalsE Elmore, M P FitzgeraldInternational Urogynecology Journal and Pelvic Floor Dysfunction|October 8, 2003
Rehabilitation of the short pelvic floor. I: Background and patient evaluationM P FitzGerald, R KotarinosPageof 38